Serum Institute CEO Adar Poonawalla tells NDTV that testing is underway to demonstrate the efficacy of the Oxford-AstraZeneca vaccine against the mutant strains of the coronavirus. Serum Institute is also looking to test the safety and immunogenicity of the vaccination among children. "Some of those vaccinated have been infected by the UK strain, but the cases are largely asymptomatic," says Adar Poonawalla. "90% effectiveness against hospitalisations has been validated," he adds.
NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.
Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.
Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
- Category
- Asia
- Tags
- NDTV 24x7, Covid Vaccine, Coronavirus
Sign in or sign up to post comments.
Be the first to comment